A CANS-seminar with focus on clinical microbiology. Presenters:

Beyond S, I and R: The Hidden World of Clinical Breakpoints
How microbiology, pharmacology and clinical evidence are translated into treatment decisions
Paul Christoffer Lindemann is a lead consultant clinical microbiologist at the Department of Microbiology, Haukeland University Hospital, Bergen, Norway. He serves as Vice Chair of both the European Committee on Antimicrobial Susceptibility Testing (EUCAST) and the Norwegian Working Group on Antibiotics (NWGA/AFA), and has represented Norway on the EUCAST Steering Committee since 2015.
His work focuses on antimicrobial susceptibility testing, antimicrobial resistance, clinical breakpoint development, and the integration of medical microbiology into clinical decision-making. He is actively involved in developing and implementing susceptibility testing standards and guidelines at both national and international levels, with the aim of improving antimicrobial therapy and patient care.

“Costly and cool, but is it a useful tool?” Rapid diagnostics of bloodstream infections (BSI) in a North Norwegian setting.
Where does the evidence on rapid diagnostics for BSI point us? Is it transferable to faraway regions with unpredictable specimen logistics?
Kristoffer H. Endresen is consultant clinical microbiologist at Nordland Hospital Trust in Bodø. He is also a PhD-student at UiT – The Arctic University of Norway, focusing on diagnostic stewardship: implementation of new diagnostic methods, rapid diagnostics, antimicrobial stewardship and antimicrobial resistance.

Klebsiella pneumoniae - just a nosocomial pathogen or a generalist?
What does a One Health study of the Klebsiella pneumoniae species complex on the strain and plasmid level in the Norwegian context show?
Iren Høyland Löhr is Head of department and chief consultant clinical microbiologist at the Department of medical microbiology at Stavanger University Hospital, and associate professor at the University of Bergen (UiB).
She is lead of the Norwegian Klebsiella pneumoniae network (www.nor-kleb.net) and was co-PI for the KLEB-GAP project led by Prof. Arnfinn Sundsfjord. She is also in the leadership of CAMRIA (West Norwegian AMR centre at UiB). Her research focuses on antimicrobial resistance in the Norwegian and global setting; Klebsiella pneumoniae hospital outbreaks, bloodstream infections, ecology and plasmids; and more recently gut microbiome, probiotics and antibiotics in infants and children.
